Read articles from Europe

April 03, 2026 by ssph-journal.org

Growing evidence is reshaping the debate on the public health impact of vaping as it increasingly overtakes smoking among certain populations. Recent research highlights that the majority of e-cigarette users are current or former smokers, suggesting that use is largely concentrated among those already exposed to tobacco. Biomarker studies indicate that individuals who switch completely from smoking to e-cigarettes can experience substantial reductions—often exceeding 90%—in exposure to key toxicants linked to tobacco-related disease. At the same time, the findings emphasise that patterns such as dual use remain common and represent a more complex risk profile, with partial reductions in harm rather than complete elimination. The research underscores a broader shift towards viewing nicotine use along a continuum of risk, raising important questions about how harm reduction, cessation, and population-level outcomes should be balanced in public health policy.

April 03, 2026 by tobaccoreporter.com

British American Tobacco has withdrawn its nicotine pouch products from the French market following the implementation of a nationwide ban on oral nicotine products. The move comes in response to a government decree that took effect in April 2026, prohibiting the sale and distribution of such products. At the same time, the company has strongly criticised the decision, arguing that the ban was introduced without parliamentary debate or broader consultation. BAT contends that the measure runs counter to harm reduction strategies and could undermine efforts to reduce smoking rates by limiting access to lower-risk alternatives. The development highlights ongoing tensions between national regulatory approaches and wider European discussions on how to manage emerging nicotine products within a coherent public health framework.

April 02, 2026 by parliamentnews.co.uk

Growing criticism is emerging over proposals to extend smoking-style bans to vaping in public places, with some commentators arguing that such measures lack a solid scientific basis. Critics point to existing evidence suggesting that second-hand exposure to vapour poses minimal risk to bystanders, questioning the justification for stricter restrictions. Concerns are also being raised that expanding bans could blur the distinction between smoking and vaping, potentially discouraging smokers from switching to lower-risk alternatives. The argument further suggests that implementing such policies may lead to unintended consequences, including reinforcing misconceptions about relative harm and misallocating public resources. At the centre of the debate is a broader question about whether public health policy should prioritise precautionary restrictions or remain closely aligned with existing scientific evidence on risk and exposure.

April 02, 2026 by vaping360.com

France has introduced one of the strictest approaches in Europe to nicotine pouches, with new rules criminalising not only their sale but also personal possession and use. As of April 2026, these products are classified as a “toxic substance” under a health ministry decree, placing them under severe legal restrictions. Unlike in most other countries, individuals found in possession of nicotine pouches could face significant penalties, including large fines and even prison sentences under existing public health laws. The ban also extends beyond pouches to cover other non-medicinal oral nicotine products, while exempting approved nicotine replacement therapies. This move highlights an increasingly strict regulatory stance in France, and has sparked wider debate about proportionality, enforcement, and the role of alternative nicotine products within public health policy.

April 01, 2026 by snusforumet.se

Sweden has reached a significant public health milestone, with daily smoking rates falling to just 3.7 percent—well below the threshold commonly used to define a “smoke-free” society. This places the country at the forefront of global efforts to reduce smoking prevalence, far ahead of most EU member states. The achievement is often linked to long-term trends showing a steady decline in cigarette use alongside the availability of alternative nicotine products. Sweden has consistently recorded some of the lowest smoking rates in Europe, reinforcing its position as a leading case study in tobacco control. The milestone is now fuelling wider debate about which policies and behavioural shifts have driven this progress, and whether similar approaches could be replicated in other countries.

April 01, 2026 by thecritic.co.uk

Growing criticism is emerging around the UK’s Tobacco and Vapes Bill, with some commentators arguing that the legislation could undermine its own public health objectives. Critics claim that measures such as the generational smoking ban and tighter restrictions on alternative nicotine products risk driving consumers towards illicit markets rather than reducing overall harm. Concerns are also being raised about the potential unintended consequences for small retailers and the wider high street, as stricter rules may disproportionately impact legal businesses while leaving illegal trade less affected. The argument centres on whether innovation—particularly the rise of vaping and other alternatives—has already played a significant role in reducing smoking rates without the need for heavy-handed regulation. At the heart of the debate is a broader question about the effectiveness of prohibition-style policies versus harm reduction approaches in achieving long-term public health goals.

April 01, 2026 by planetofthevapes.co.uk

The UK Parliament has moved a step closer to finalising the Tobacco and Vapes Bill after accepting amendments introduced by the House of Lords. The changes focus largely on strengthening enforcement mechanisms and refining how the legislation will be implemented in practice. Key provisions include adjustments to areas such as age verification requirements and regulatory oversight, reflecting recommendations from parliamentary committees and ongoing consultations. The acceptance of these amendments signals broad political support for tightening controls on tobacco and vaping products, particularly in response to concerns about youth uptake. At the same time, debate continues over the potential impact of the measures on adult smokers and the role of harm reduction.

March 31, 2026 by nnalliance.org

A campaign has been launched opposing a proposed public vaping ban, with supporters encouraged to take part in a government consultation and contact their Members of Parliament. The initiative highlights concerns that the proposed restrictions are not sufficiently supported by evidence of public health benefit, particularly regarding exposure risks to bystanders. It also emphasises the importance of incorporating real-world experiences into policymaking processes, especially from individuals who have used vaping as a tool to quit smoking. The campaign argues that vaping is significantly less harmful than smoking and suggests that overly broad restrictions could undermine harm reduction efforts. Public participation is being encouraged through submissions to the consultation process and the sharing of personal testimonies.

March 31, 2026 by brusselssignal.eu

Growing concern is being voiced by some researchers that the European Union’s approach to vaping may be moving away from scientific evidence and real-world outcomes. A leading expert in tobacco harm reduction warns that stricter regulations and higher taxes on nicotine alternatives could risk reversing progress in reducing smoking rates. Criticism focuses on what is seen as a failure to properly distinguish between combustible cigarettes and lower-risk alternatives such as e-cigarettes and nicotine pouches. Examples such as Sweden are frequently highlighted, where widespread adoption of harm reduction products has contributed to some of the lowest smoking rates in Europe. There are also concerns that restrictive policies could unintentionally drive consumers back to smoking or toward illicit markets if safer alternatives become less accessible or more expensive. The debate ultimately reflects a broader clash between precautionary regulation and evidence-based public health strategies in shaping the future of nicotine policy across the EU.

March 31, 2026 by seenews.com

North Macedonia is intensifying oversight of its medical cannabis sector after uncovering widespread irregularities among licensed producers. Authorities have revoked additional licences from several companies following inspections that identified legal and operational breaches. The move follows earlier enforcement actions and large-scale seizures of cannabis allegedly diverted from legal production into illicit markets. Officials have announced broader inspections across the entire industry, signalling concerns about systemic weaknesses in regulatory control. The developments highlight growing pressure to tighten governance and ensure transparency in a rapidly expanding medical cannabis market.